Bespak logo — Bespak is a global contract development and manufacturing or...

Bespak

Bespak is a global contract development and manufacturing organisation (CDMO) focused on inhaled and nasal drug delivery

Founded 1959 United Kingdom Holmes Chapel, United Kingdom 622 employees Grant Health Care, Manufacturing

General Information

Company Name Bespak
Founded Year 1959
Location United Kingdom Holmes Chapel, United Kingdom
Employees 622
Industries Health Care, Manufacturing
Funding Stage Grant
Business Model B2B, White Label
Revenue Model Service Fee, Product Sales
Offices as of Sep 2026
Holmes Chapel, United Kingdom Kings Lynn, United Kingdom
Social

BounceWatch is an independent company data service, not affiliated with Bespak. To contact Bespak, visit bespak.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Sep 07, 2026

Bespak's team is attending the Exploring the Future of Inhalation Drug Delivery event in Parma from September 8-11, with Miles Kottman presenting.

About Bespak

Bespak, established in 1959, is a leading global Contract Development and Manufacturing Organisation (CDMO) with a core focus on inhaled and nasal drug delivery. Positioned strategically within the intersection of health care and manufacturing, Bespak has carved out a significant niche as a supplier of drug delivery devices and componentry to the pharmaceutical industry.

Headquartered in Holmes Chapel, UK, Bespak's comprehensive service suite spans the entire product lifecycle. The company is distinguished by its expertise in the development and mass production of complex dry powder inhaler (DPI) devices and pressurised Metered Dose Inhalers (pMDIs). It holds a substantial market share in pMDI dosing valves, evidencing its technical and commercial prowess.

Despite its substantial legacy, Bespak has not reported any recent external investments, hinting at a possibly stable or internally-driven growth strategy. This could represent a unique opportunity for potential investors looking to penetrate the niche market of drug-device combination products.

Taxonomy: Inhaled Drug Delivery, Nasal Drug Delivery, Contract Development and Manufacturing, Pressurised Metered Dose Inhalers (pMDIs), Dry Powder Inhaler (DPI) Devices, Drug-Device Combination Products, Pharmaceutical Fill-Finish, Device and Component Manufacturing, Continuous Improvement, Design for Manufacture, Pilot-scale Manufacturing, Clinical-scale Manufacturing, Commercial-scale Manufacturing, Low GWP Propellants, Plastic Injection Moulding

Services & Products

Device Design and Development
Drug Product Development
Regulatory Approval
Commercial Manufacturing
Scale Up and Tech Transfer
Sustainability Initiatives

Target Customers

Pharmaceutical Companies Healthcare Providers Patients Needing Inhalation Therapies

No funding data available for Bespak yet.

Bespak Alternatives & Competitors

Bespak vs

We CARE. We CREATE. We DELIVER.

Grant
326 employees
Biotechnology, Health Care
Bespak vs

Le persone al centro del nostro universo

4 employees
Health Care, Manufacturing

FAQ About Bespak

Bespak is a global contract development and manufacturing organisation (CDMO) focused on inhaled and nasal drug delivery
Bespak was founded in 1959.
Bespak is headquartered in Holmes Chapel, United Kingdom. As of Sep 2026, it also has offices in Kings Lynn, United Kingdom.
Bespak operates in Health Care and Manufacturing. Its work centres on Inhaled Drug Delivery, Nasal Drug Delivery, Contract Development and Manufacturing and Pressurised Metered Dose Inhalers (pMDIs). Its customers include Pharmaceutical Companies, Healthcare Providers and Patients Needing Inhalation Therapies.
Bespak has a B2B and White Label business model. Its revenue comes from Service Fee and Product Sales.
Bespak has approximately 622 employees.
Bespak offers: Device Design and Development, Drug Product Development, Regulatory Approval, Commercial Manufacturing, Scale Up and Tech Transfer, Sustainability Initiatives.
Top alternatives and competitors to Bespak include LTS Lohmann Therapie-Systeme AG, NEWPHARM MEDICAL. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bespak and LTS Lohmann Therapie-Systeme AG are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bespak, https://bouncewatch.com/company/bespak, updated 11 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes